Skip to content

EPIZYME, INC.

CIK 0001571498

← back to feed
Revenue (TTM)
$19.59M
−24.9% YoY Q2 Aug 2022
Net Income (TTM)
−$221.45M
−279.1% YoY Q2 Aug 2022
EPS Diluted (TTM)
−$1.86
−276.9% YoY Q2 Aug 2022
Gross Margin
37.2%
Q2 Aug 2022
Operating Margin
-1,036.7%
Q2 Aug 2022
Net Margin
-1,130.3%
Q2 Aug 2022
Free Cash Flow (TTM)
−$224.81M
Q2 Aug 2022
Cash
$71.07M
Q2 Aug 2022
Total Debt
$216.89M
Q2 Aug 2022
Shares Outstanding
168.36M sh
Q2 Aug 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings